Equities analysts expect that Genpact Limited (NYSE:G) will post $808.25 million in sales for the current fiscal quarter, Zacks reports. Seven analysts have issued estimates for Genpact’s earnings, with estimates ranging from $794.34 million to $822.55 million. Genpact reported sales of $734.41 million in the same quarter last year, which indicates a positive year-over-year growth rate of 10.1%. The company is expected to issue its next earnings report on Monday, February 11th.
According to Zacks, analysts expect that Genpact will report full year sales of $2.97 billion for the current year, with estimates ranging from $2.96 billion to $2.99 billion. For the next year, analysts forecast that the firm will report sales of $3.28 billion, with estimates ranging from $3.24 billion to $3.38 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Genpact.
Genpact (NYSE:G) last posted its earnings results on Tuesday, November 6th. The business services provider reported $0.48 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.45 by $0.03. The company had revenue of $747.98 million during the quarter, compared to analysts’ expectations of $754.93 million. Genpact had a net margin of 9.31% and a return on equity of 22.26%. Genpact’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period last year, the company posted $0.46 earnings per share.
Several research firms have commented on G. Wells Fargo & Co set a $32.00 price objective on shares of Genpact and gave the company a “hold” rating in a research report on Wednesday, November 7th. Zacks Investment Research lowered shares of Genpact from a “buy” rating to a “hold” rating in a report on Monday, September 10th. JPMorgan Chase & Co. lowered shares of Genpact from a “neutral” rating to an “underweight” rating and set a $37.00 price target for the company. in a report on Tuesday, August 14th. Cantor Fitzgerald reissued a “buy” rating and issued a $36.00 price target on shares of Genpact in a report on Wednesday, November 7th. Finally, Cowen reissued a “buy” rating and issued a $35.00 price target on shares of Genpact in a report on Wednesday, November 7th. One analyst has rated the stock with a sell rating, four have given a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $34.31.
G traded down $0.15 during trading on Monday, hitting $28.42. 646,788 shares of the company traded hands, compared to its average volume of 780,256. The stock has a market capitalization of $5.45 billion, a price-to-earnings ratio of 19.07, a PEG ratio of 1.83 and a beta of 0.71. Genpact has a 1 year low of $26.46 and a 1 year high of $34.79. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.31 and a current ratio of 1.31.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 19th. Investors of record on Monday, December 10th will be issued a $0.075 dividend. This represents a $0.30 annualized dividend and a yield of 1.06%. The ex-dividend date is Friday, December 7th. Genpact’s payout ratio is presently 20.13%.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Brown Advisory Inc. boosted its position in shares of Genpact by 8.9% during the 2nd quarter. Brown Advisory Inc. now owns 13,753,374 shares of the business services provider’s stock valued at $397,884,000 after acquiring an additional 1,129,478 shares during the last quarter. Vanguard Group Inc. raised its position in Genpact by 0.4% during the third quarter. Vanguard Group Inc. now owns 12,373,412 shares of the business services provider’s stock valued at $378,750,000 after buying an additional 52,109 shares during the period. FMR LLC raised its position in Genpact by 3.5% during the second quarter. FMR LLC now owns 9,813,587 shares of the business services provider’s stock valued at $283,907,000 after buying an additional 328,676 shares during the period. Fiduciary Management Inc. WI raised its position in Genpact by 6.0% during the third quarter. Fiduciary Management Inc. WI now owns 4,735,755 shares of the business services provider’s stock valued at $144,961,000 after buying an additional 268,585 shares during the period. Finally, Alliancebernstein L.P. raised its position in Genpact by 20.1% during the third quarter. Alliancebernstein L.P. now owns 3,612,107 shares of the business services provider’s stock valued at $110,567,000 after buying an additional 603,618 shares during the period. 89.43% of the stock is owned by institutional investors.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; over-the counter services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.
Recommended Story: Cost of Capital
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.